Birdwatch Note
2023-06-06 19:34:04 UTC - NOT_MISLEADING
Ivermectin shown effective: Treated w/HFA & Ivermectin called with “W” vs HFA alone called without “WO” Mortality: W-20% WO-30% Extubated/O2>90%: W-46.7% WO-36.7% Resp imp >95%/not intub.: W/73.3% WO/53.3% Serum Lymph. (T-cells) better/higher: W-932 1273 WO-1010 968 https://www.clinicaltrials.gov/ct2/show/results/NCT04646109?term=ivermectin&cond=COVID-19&draw=2&rank=5&view=results
Written by D13535653FA1C2ABF06EFD3D1DFA286B501D64BCEA8F153313B21698FDEAF063
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1666076986694049792
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1666166584585617408
- noteId - 1666166584585617408
- participantId -
- noteAuthorParticipantId - D13535653FA1C2ABF06EFD3D1DFA286B501D64BCEA8F153313B21698FDEAF063 Participant Details
- createdAtMillis - 1686080044300
- tweetId - 1666076986694049792
- classification - NOT_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 1
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Ivermectin shown effective: Treated w/HFA & Ivermectin called with “W” vs HFA alone called without “WO” Mortality: W-20% WO-30% Extubated/O2>90%: W-46.7% WO-36.7% Resp imp >95%/not intub.: W/73.3% WO/53.3% Serum Lymph. (T-cells) better/higher: W-932 1273 WO-1010 968 https://www.clinicaltrials.gov/ct2/show/results/NCT04646109?term=ivermectin&cond=COVID-19&draw=2&rank=5&view=results
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-06-06 19:34:04 UTC (1686080044300) |
1969-12-31 23:59:59 UTC (-1) |
2023-06-07 02:40:34 UTC (1686105634600) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-06-06 19:27:00 -0500 | Rating Details | |
| 2023-06-06 18:51:59 -0500 | Rating Details | |
| 2023-06-06 18:44:08 -0500 | Rating Details | |
| 2023-06-06 18:35:10 -0500 | Rating Details | |
| 2023-06-06 18:30:13 -0500 | Rating Details | |
| 2023-06-06 18:24:10 -0500 | Rating Details | |
| 2023-06-06 18:03:32 -0500 | Rating Details | |
| 2023-06-06 17:45:58 -0500 | Rating Details | |
| 2023-06-06 17:22:38 -0500 | Rating Details | |
| 2023-06-06 17:17:16 -0500 | Rating Details | |
| 2023-06-06 17:15:39 -0500 | Rating Details | |
| 2023-06-06 17:05:12 -0500 | Rating Details | |
| 2023-06-06 16:41:16 -0500 | Rating Details | |
| 2023-06-06 16:36:54 -0500 | Rating Details | |
| 2023-06-06 16:33:32 -0500 | Rating Details | |
| 2023-06-06 16:28:52 -0500 | Rating Details | |
| 2023-06-06 16:22:33 -0500 | Rating Details | |
| 2023-06-06 16:22:02 -0500 | Rating Details | |
| 2023-06-06 16:18:56 -0500 | Rating Details | |
| 2023-06-06 16:13:55 -0500 | Rating Details | |
| 2023-06-06 16:06:45 -0500 | Rating Details | |
| 2023-06-06 15:58:05 -0500 | Rating Details | |
| 2023-06-06 15:55:40 -0500 | Rating Details | |
| 2023-06-06 15:41:17 -0500 | Rating Details | |
| 2023-06-06 15:38:08 -0500 | Rating Details | |
| 2023-06-06 15:28:14 -0500 | Rating Details | |
| 2023-06-06 15:15:56 -0500 | Rating Details | |
| 2023-06-06 15:14:32 -0500 | Rating Details | |
| 2023-06-06 15:08:13 -0500 | Rating Details | |
| 2023-06-06 14:58:25 -0500 | Rating Details | |
| 2023-06-06 14:55:46 -0500 | Rating Details | |
| 2023-06-06 14:44:42 -0500 | Rating Details | |
| 2023-06-07 17:00:09 -0500 | Rating Details | |
| 2023-06-07 09:47:33 -0500 | Rating Details | |
| 2023-06-07 09:18:56 -0500 | Rating Details | |
| 2023-06-07 09:14:02 -0500 | Rating Details | |
| 2023-06-07 07:36:54 -0500 | Rating Details | |
| 2023-06-07 07:20:04 -0500 | Rating Details | |
| 2023-06-07 05:11:26 -0500 | Rating Details | |
| 2023-06-07 05:09:39 -0500 | Rating Details | |
| 2023-06-07 02:19:03 -0500 | Rating Details | |
| 2023-06-07 01:23:48 -0500 | Rating Details | |
| 2023-06-07 00:44:03 -0500 | Rating Details | |
| 2023-06-07 00:08:19 -0500 | Rating Details | |
| 2023-06-06 23:55:00 -0500 | Rating Details | |
| 2023-06-06 22:42:10 -0500 | Rating Details | |
| 2023-06-06 22:19:04 -0500 | Rating Details | |
| 2023-06-06 22:17:17 -0500 | Rating Details | |
| 2023-06-06 21:57:15 -0500 | Rating Details | |
| 2023-06-06 20:10:04 -0500 | Rating Details | |
| 2023-06-06 20:07:27 -0500 | Rating Details | |
| 2023-06-06 19:47:08 -0500 | Rating Details | |
| 2023-06-06 19:37:36 -0500 | Rating Details | |
| 2023-06-08 21:40:37 -0500 | Rating Details | |
| 2023-06-14 04:28:13 -0500 | Rating Details | |
| 2023-06-14 04:26:53 -0500 | Rating Details |